Clinical Trial Update: TUC3PII-01_TU2670 Phase IIa Clinical Study [Phase 2]

View source ↗

Summary

A Phase IIa clinical trial TU2670 for endometriosis conducted by TiumBio has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• TU2670

Snippet

Sponsor: TiumBio Co., Ltd. | Conditions: Endometriosis | Phase 2 | Status: COMPLETED